November 5, 2010 – Cardiovascular Systems Inc. (CSI) will pay $1 million to settle an employment lawsuit with ev3, which is now part of Covidien.
The litigation stems from a lawsuit ev3 originally filed in 2007 related to ev3 employees who joined Cardiovascular Systems Inc.
Neither party admits any liability or wrongdoing. Both companies develop transcatheter atherectomy devices for use in peripheral artery disease (PAD).
For more information: www.csi360.com
Medtronic recently announced results from two studies evaluating the utility of atherectomy for peripheral endovascular ...
November 08, 2024 
February 15, 2023 — Abbott and Cardiovascular Systems, Inc. (CSI), announced a definitive agreement for Abbott to ...
February 15, 2023 
July 28, 2022 — Northeast Scientific Inc., pioneers in reprocessing single use peripheral vascular catheters, announced ...
July 28, 2022 
March 9, 2022 — Medtronic is recalling (correcting) the TurboHawk Plus Directional Atherectomy System due to design ...
March 09, 2022 
January, 24, 2022 — Medtronic Inc. is recalling its HawkOne Directional Atherectomy System product due to the risk of ...
January 24, 2022 
January 10, 2022 — Cardiovascular Systems Inc. (CSI) is recalling the Wirion atherectomy embolic protection device ...
January 10, 2022 
July 20, 2020 – BD (Becton, Dickinson and Company) recently completed the acquisition of Straub Medical AG, a privately ...
July 20, 2020 
February 13, 2020 — The U.S. Food and Drug Administration (FDA) has issued its final guidance on "Peripheral Vascular ...
February 13, 2020 
November 7, 2019 — The REVEAL FDA investigational device exemption (IDE) trial confirmed a favorable safety and ...
November 11, 2019 
November 7, 2019 — There was no difference between drug-coated balloons (DCB) vs. plain old balloon angioplasty (POBA) ...
November 07, 2019